The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data

被引：0
|
作者：
Lerman, T. [1 ]
Yacoby, I [1 ]
Fishman, B. [2 ]
Goldman, A. [2 ]
Talmor-Barkan, Y. [1 ]
Itelman, E. [1 ]
Orvin, K. [1 ]
Eisen, A. [1 ]
Kornowski, R. [1 ]
Levi, A. [1 ]
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Sheba Med Ctr, Ramat Gan, Israel
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A real-world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib
    Yin, Yi
    Sun, Fengli
    Jin, Youpeng
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System Events for Trametinib
    Zhang, Xinyue
    Li, Rongrong
    Li, Yanrong
    He, Lu
    Hou, Encun
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [33] A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
    He, Ke
    Zhao, Kaidi
    Yin, Tingyi
    Liu, Meng
    Liu, Jiashu
    Du, Wenqian
    Liu, Xinyi
    Cheng, Baochen
    Zhang, Dewu
    Zheng, Yan
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [34] Real-world pharmacovigilance study of FDA adverse event reporting system events for finerenone
    Huang, Youqi
    Gao, Hongjin
    Lin, Yuze
    Chen, Xiaowen
    Chen, Mingyu
    Chen, Min
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [35] A real-world pharmacovigilance study of blinatumomab based on the FDA adverse event reporting system
    Zhang, Zheng
    Guo, Wenhao
    Chen, Minghao
    Yang, Qianzhi
    Song, Xia
    Wang, Yuping
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [36] Safety of talimogene laherparepvec: a real-world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
    Hong, Yifan
    Cheng, Kebin
    Qu, Han
    Wang, Yuting
    Wang, Yuanyuan
    Fan, Guorong
    Wu, Zhenghua
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):
  • [37] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine
    Zhang, Cheng
    Li, Ke
    Xu, Shu-Ning
    Qiao, Lei
    Ren, Yu-Lin
    Li, Qun
    Liu, Ying
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 365 - 376
  • [38] Post-marketing safety of tralokinumab: a real-world pharmacovigilance study based on the FDA adverse event reporting system
    Yang, Zeping
    Tang, Kejing
    Chen, Jie
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1439 - 1446
  • [39] REZUM IN THE GOLDEN YEARS: REAL-WORLD FUNCTIONAL OUTCOMES IN MEN OLDER THAN 75 YEARS
    Ferreira, Roseanne
    Bhojani, Naeem
    Chughtai, Bilal
    Zorn, Kevin C.
    Elterman, Dean
    JOURNAL OF UROLOGY, 2024, 211 (05): : E430 - E431
  • [40] Sex Differences in Risk for Iatrogenic Thyrotoxicosis Among Older Adults: An Analysis from Real-World Clinical Data
    Adams, Roy
    Mammen, Jennifer Sophie
    THYROID, 2025,
12345